medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2003, Number 3

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2003; 16 (3)

Lung mucormycosis in a case of small cell bronchogenic carcinoma with type 2 diabetes mellitus.

Fujarte VAS, Casillas SC, Flores CI, Alonso RP, Cicero SR

Language: Spanish
References: 15
Page: 169-172
PDF size: 91.56 Kb.


ABSTRACT

Infection by opportunistic microorganisms, including fungus, is common in immunocompromised hosts, among them lung carcinoma patients. These represent a diagnostic and therapeutic challenge. A case of small cell carcinoma with diabetes mellitus type 2 and Mucor infection is reported. Case. Male 57 years old. Clinical evolution of five months with dysphagia, odinophagia, pleuritic pain on the right side, cough with no sputum and weight loss of 5kg. Chest X-rays and CT revealed opacity in the upper right lobe with cavities. Fiberoptic bronchoscopy demonstrated a tumoral occlusion of the right upper lobe bronchus and extrinsic compression of the main stem bronchus. Bronchial biopsy, bronchial lavage and brushing were reported as small cell carcinoma coincident with mucormycosis. Mucor was depicted with special stains and culture. Treatment with amphotericin B was successful and chemotherapy was instituted for the small cell carcinoma. Relevant issues of the literature are revised.


REFERENCES

  1. Fanta ChH, Pennington JE. Pneumonia in the immunocompromised host. In: Pennington JE, editor. Respiratory infections. Diagnosis and management. NY: Raven Press, 1994:275-294.

  2. Fraser R, Paré JA, Fraser R, Paré PD. Hongos y actinomices. En: Diagnóstico de las enfermedades del tórax. 4a ed. Volumen II (traducción). México: Panamericana, 1999: 936-938.

  3. Fishman´s. Pulmonary diseases and disorders: Aspergillus syndromes, mucormycosis and pulmonary candidiasis. NY: Mc. Graw Hill, 1998:2281-2284.

  4. Niederman. Respiratory infections: Nontransplant patients with chemotherapy immunosuppression. 2da ed. Philadelphia: Lippincott Williams & Wilkins, 2001:223-224.

  5. Leher RI. UCLA Conference. Mucormycosis. Ann Intern Med 1980;93:93-108.

  6. Talib M. Myelodysplasia, deferoxamine and pulmonary mucormycosis. Chest 2002;122:244S- 245S.

  7. Virally ML. Pulmonary mucormycosis in a diabetic patient with HIV. Diabetes Care 2002;25:2105-2106.

  8. Wohlrab JL, Anderson ED. A patient with myelodysplastic syndrome, pulmonary nodules, and worsening infiltrates. Chest 2001;120:1014-1017.

  9. Goring KL. Pulmonary mucormycosis: A descriptive case series. Chest 2000; 118:245S-246S.

  10. Cuvelier I, Vogelaers D, Poleman R, Benoit D, Van M, Offner F, et al. Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review. Eur J Clin Microbiol Infec Dis 1998;17:859-863.

  11. Nourdine K, Telfour A, Antonie M, Roux P, Zini JM, Cadranel J. Pulmonary mucormycosis in a leukemia patient. Diagnostic and therapeutic difficulties. Rev Mal Respir 1997;14:502-505.

  12. Fukushima T, Sumazaki R, Shibasaky M, Saitoh H, Fujigaki Y, Kaneko M, et al. Successful treatment of invasive thoracopulmonary mucormycosis in a patient whit acute lymphoblastic leukemia. Cancer 1995;76:895-899.

  13. Featherston PL, Fernández G, Munguía H, Marín ME. Mucormycosis: Study of five cases found in San Juan de Dios Hospital and Sor María Ludovica Hospital in La Plata, Argentina. Rev Argent Microbiol 1998;30:176-179.

  14. Glazer M. The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 2000;117:279-282.

  15. Hinerman R. Treatment of endobronchial mucormycosis with amphotericin B via flexible bronchoscopy. J Bronchol 2002;9:294-297.




2020     |     www.medigraphic.com